5 Stocks Under $10 Set to Trade Higher in November
Anthera Pharmaceuticals
One under-$10 name in the biotechnology and drugs complex that's moving within range of triggering a near-term breakout trade is Anthera Pharmaceuticals (ANTH). This company is focusing on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. This stock has been destroyed by the bears so far in 2012, with shares down by over 80%.
If you take a look at the chart for Anthera Pharmaceuticals, you'll that this stock has been trending sideways for the last two months, with shares moving between 81 cents on the downside and $1.29 on the upside. Shares of ANTH have just today started to challenge its 50-day at 98 cents per share, and it's quickly moving within range of triggering a major breakout trade above some near-term overhead resistance levels.
Traders should now look for long-biased trades in ANTH once it manages to break out above some near-term overhead resistance levels at $1.07 to $1.29 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 1,130,750 shares. If that breakout triggers soon, then ANTH will set up for a potentially explosive move higher back towards its next major overhead resistance level at $1.79 a share. Any high-volume move above $1.79 will give ANTH a chance to re-fill some of its previous gap down zone that started at around $2.80 a share.
Traders can look to buy ANTH as long as it's trending above today's low of 95 cents per share with strong upside volume flows. You can also buy off strength once ANTH takes out $1.07 to $1.29 a share with volume, and then simply use a stop that sits just below its 50-day at 98 cents per share.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV